Transform Your Pharma Operations with AI-Powered Intelligence. Experience how Leucine's integrated platform brings together manufacturing, quality, and laboratory operations in one digital ecosystem. Schedule a personalized demo to see how our AI solutions can optimize your processes, ensure compliance, and drive operational excellence.
See How AI Transforms Your Shop Floor Operations.
Experience firsthand how Leucine's 10x MES digitalizes batch records, streamlines production, and provides real-time monitoring of your manufacturing operations. Schedule a personalized demo to discover how our AI-powered platform can enhance your productivity while maintaining compliance.
Experience AI-Driven Quality Management in Action.
See how Leucine's 10x QMS automates compliance workflows, streamlines change control, and ensures regulatory adherence. Schedule a demo to learn how our AI-powered platform can help you manage quality processes more efficiently while reducing compliance risks.
Discover Smart Laboratory Operations Management.
Watch how Leucine's 10x LES orchestrates your lab operations, automates documentation, and ensures data integrity. Schedule a demo to see how our AI-powered platform can accelerate your testing processes while maintaining audit-readiness.
TITLE/ COMPANY | Issue Date | Status | Details |
---|---|---|---|
Written procedures are not followed for evaluations conducted to review records associated with batches Carma Laboratories, Inc. |
14 Nov 2023 | Normal | Justification: The deficiencies in conducting and closing APRs directly fall under Annual Product Quality Review as process type. Excerpt: Specifically, Your firm failed to perform Annual Product Review (APR) for Domestic Lip Balm Stick and Domestic Lip Balm Tube for the year of 2022. According to your written procedure, individual APR are completed (b) (4) . Additionally, your procedure is deficient for the closure of APRs on a timely manner. For example, APR for Domestic Lip Balm Stick review period (1/1/2021 - 12/31/2021) was not completed until 12/29/2022. View Details |
Failure of your quality unit to perform an annual product review Brenntag Great Lakes, LLC |
05 May 2023 | Normal | Justification: The observation specifically mentions a failure to perform annual product reviews, which directly relates to the 'Annual Product Quality Review' process type. Excerpt: Failure of your quality unit to perform an annual product review. Specifically, Your Quality Unit failed to perform annual product review for the following products. View Details |
Written procedures are not established for evaluations conducted at least annually to review records associated with a representative number of batches H J Harkins Company Inc dba Pharma Pac |
03 Mar 2023 | Normal | Justification: The observation specifically mentions the lack of annual evaluations, which is a core requirement of Annual Product Quality Review. Excerpt: Your firm has not conducted any annual evaluations for the products you repack. View Details |
Written procedures are not followed for evaluations conducted at least annually to review records associated with a representative number of batches Sina Health Inc |
13 Jan 2023 | Normal | Justification: Annual Product Quality Review is directly linked since the observation indicates a failure to conduct required annual evaluations. Excerpt: Your firm has not completed (b) (4) evaluations from 2017-2021. View Details |
The responsibilities and procedures applicable to the quality control unit are not fully followed Orly International, Inc. |
20 Dec 2022 | Normal | Justification: Annual product quality review ensures continuous product suitability and quality consistency. Excerpt: Your firm does not perform annual product reviews for OTC hand sanitizer and antifungal drug products. View Details |